You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Baxter
Moodys
Merck
Dow

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Peanut - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for peanut

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Institut de Recherche en Sciences de la Sante, Burkina FasoN/A
Massachusetts General HospitalPhase 2
InnoUp Farma S.L.Phase 1/Phase 2

See all peanut clinical trials

Recent Litigation for peanut

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
RTW Retailwinds, Inc.2020-07-13
CHIESI USA, INC. v. AUROBINDO PHARMA USA, INC.2019-10-07
Onyx Therapeutics, Inc. v. Breckenridge Pharmaceutical, Inc.2019-01-11

See all peanut litigation

PTAB Litigation
PetitionerDate
Commonwealth Scientific and Industrial Research Organisation2020-04-16
Gibson Overseas, Inc.2019-07-22
REG Synthetic Fuels, LLC2018-08-03

See all peanut litigation

Patent Text Search: US Patents for peanut

These patents were identified by searching patent claims

Supplementary Protection Certificates for peanut

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0973 Netherlands   Start Trial DETAILS ASSIGNMENT: CHANGE OF OWNER(S), CHANGE OF OWNER(S) NAME
90012-5 Sweden   Start Trial PRODUCT NAME: ENCORAFENIB OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEROF; REG. NO/DATE: EU/1/18/1314 20180924
2016000047656 Italy   Start Trial PRODUCT NAME: CARFILZOMIB OPZIONALMENTE IN FORMA DI UN SALE FARMACEUTICAMENTE ACCETTABILE(KYPROLIS); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/15/1060, 20151123
05C/036 Belgium   Start Trial PRODUCT NAME: CEFTIOFUR; AUTHORISATION NUMBER AND DATE: EU/2/05/053/001 20050520
71016 Netherlands   Start Trial PRODUCT NAME: AZOXYSTROBINE, DESGEWENST IN DE VORM VAN EEN ZOUT; NAT. REGISTRATION NO/DATE: 11767 N 19961122; FIRST REGISTRATION: DE 04248-00 19960404
C0047 Belgium   Start Trial PRODUCT NAME: AZOXYSTROBIN; NAT. REGISTRATION NO/DATE: 8898/B 19970129; FIRST REGISTRATION: DE 04248-00 19960404
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Colorcon
Dow
Boehringer Ingelheim
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.